Endocrine factors associated with infertility in women: an updated review

References

• Sahana Devi KJ, Yendapalli V. Women infertility: a systematic review of effects and causes. SN Comput Sci. 2022 Dec 17;4(2):103.
   Google Scholar
• Infertility Prevalence Estimates , 1990–2021. [Internet]. Geneva: World Health Organization; 2023. [cited 2023 Jun 13] 79 Available from: https://www.who.int/publications-detail-redirect/978920068315
   Google Scholar
• Walker MH, Tobler KJ. Female infertility. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jun 25]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK556033/
   Google Scholar
• Barrera N, Omolaoye TS, Du Plessis SS. Chapter 6 - a contemporary view on global fertility, infertility, and assisted reproductive techniques. In: Vaamonde D, Hackney A Garcia-Manso J, editors. Fertility, pregnancy, and wellness [internet]. Elsevier; 2022. p. 93–120. cited 2023 Jun 28 Available from:https://www.sciencedirect.com/science/article/pii/B9780128183090000095
   Google Scholar
• Barbieri RLFemale infertility. Yen And Jaffe’s Reproductive Endocrinology [Internet]. Elsevier; 2019 [cited 2023 Jun 13]. 556–581.e7. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323479127000226
   Google Scholar
• Unuane D, Velkeniers B, Bravenboer B, et al. Impact of thyroid autoimmunity in euthyroid women on live birth rate after IUI. Hum Reprod Oxf Eng. 2017 Apr 1;32(4):915–922. doi: 10.1093/humrep/dex033
   PubMed Web of Science ®Google Scholar
• Concepción Zavaleta M, Rafael Robles L, Coronado Arroyo J, et al. Evaluación del status hormonal en infertilidad femenina. Una visión desde el punto de vista del endocrinólogo. Rev Argent Endocrinol Metab. 2022;59(1):62–68.
   Google Scholar
• Luciano AA, Lanzone A, Goverde AJ. Management of female infertility from hormonal causes. Int J Gynecol Obst. 2013 Dec 1;123:S9–17. doi: 10.1016/j.ijgo.2013.09.007
   PubMed Web of Science ®Google Scholar
• Stamatiades GA, Kaiser UB. Gonadotropin regulation by pulsatile GnRH: signaling and gene expression. Mol Cell Endocrinol. 2018 Mar 5;463:131–141. doi: 10.1016/j.mce.2017.10.015
   PubMed Web of Science ®Google Scholar
• Casteel CO, Singh G. Physiology, gonadotropin-releasing hormone. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jun 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK558992/
   Google Scholar
• Kükürt A, Kuru M, Başer ÖF, et al. Kisspeptin: role in female infertility. Reproductive Hormones [Internet]. IntechOpen; 2020 [cited 2023 Jun 24]. Available from: https://www.intechopen.com/chapters/74165
   Google Scholar
• Simerly RB. Chapter 13 - Organization of the hypothalamus. In: The rat nervous system Fourth. Paxinos G, editor. InternetAvailable from. San Diego: Academic Press. 2015. 267–294. [cited 2023 Jun 24]. Available from: https://www.sciencedirect.com/science/article/pii/B9780123742452000139.
   Google Scholar
• Uenoyama Y, Nagae M, Tsuchida H, et al. Role of KNDy neurons expressing kisspeptin, neurokinin B, and dynorphin a as a GnRH pulse generator controlling mammalian reproduction. Front Endocrinol. 2021;12: [cited 2023 Jun 24]. InternetAvailable from: doi: 10.3389/fendo.2021.724632
   PubMed Web of Science ®Google Scholar
• Weiss RV, Clapauch R. Female infertility of endocrine origin. Arq Bras Endocrinol Metabol. 2014 Mar;58(2):144–152. doi: 10.1590/0004-2730000003021
   PubMedGoogle Scholar
• Wen J, Huang K, Du X, et al. Can inhibin B reflect ovarian reserve of healthy reproductive age women effectively? Front Endocrinol. 2021;12:626534. doi: 10.3389/fendo.2021.626534
   PubMed Web of Science ®Google Scholar
• Su HW, Yi YC, Wei TY, et al. Detection of ovulation, a review of currently available methods. Bioeng Transl Med. 2017 Sep;2(3):238–246. doi: 10.1002/btm2.10058
   PubMed Web of Science ®Google Scholar
• WHO Scientific Group on Agents Stimulating Gonadal Function in the Human & World Health Organization. Agents stimulating gonadal function in the human: report of a WHO scientific group [‎meeting held in Geneva from 28 August to 1 September 1972]‎ [Internet]. Geneva: World Health Organization; 1973 30 [cited 2023 Jul 2] Available from: https://apps.who.int/iris/handle/10665/38216
   Google Scholar
• Advances in methods of fertility regulation: report of a WHO scientific group. World Health Organ Tech Rep Ser. 1973;527:1–42.
   PubMedGoogle Scholar
• Munro MG, Balen AH, Cho S, et al. The FIGO ovulatory disorders classification system. Int J Gynecol Obst. 2022;159(1):1–20. doi: 10.1002/ijgo.14331
   PubMed Web of Science ®Google Scholar
• Fertility problems: assessment and treatment | Clinical guideline [CG156] | NICE. Last Updated: 06 September 2017 [Internet]. NICE; 2013 [cited 2023 Jul 1]. Available from: https://www.nice.org.uk/guidance/cg156/chapter/recommendations
   Google Scholar
• Health (UK). NCC for W and C. Ovulation disorders. Fertility: Assessment And Treatment For People With Fertility Problems [Internet]. Royal College of Obstetricians & Gynaecologists; 2013 [cited 2023 Jul 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK327781/
   Google Scholar
• Talaulikar V, Yasmin E. WHO type 1 anovulation: an update on diagnosis, management and implications for long-term health. Obstet Gynaecol. 2020;22(3):178–190. doi: 10.1111/tog.12665
   Google Scholar
• Maggi R, Cariboni AM, Marelli MM, et al. GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Hum Reprod Update. 2016 Apr;22(3):358–381. doi: 10.1093/humupd/dmv059
   PubMed Web of Science ®Google Scholar
• Shufelt CL, Torbati T, Dutra E. Hypothalamic amenorrhea and the long-term Health consequences. Semin Reprod Med. 2017 May;35(3):256–262. doi: 10.1055/s-0037-1603581
   PubMed Web of Science ®Google Scholar
• Roberts RE, Farahani L, Webber L, et al. Current understanding of hypothalamic amenorrhoea. Ther Adv Endocrinol Metab. 2020 Jul 30;11:2042018820945854.
   Web of Science ®Google Scholar
• Gordon CM, Ackerman KE, Berga SL, et al. Functional hypothalamic amenorrhea: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017 May 1;102(5):1413–1439. doi: 10.1210/jc.2017-00131
   PubMed Web of Science ®Google Scholar
• Meczekalski B, Niwczyk O, Bala G, et al. Stress, kisspeptin, and functional hypothalamic amenorrhea. Curr Opin Pharmacol. 2022 Dec;67:102288.
   PubMed Web of Science ®Google Scholar
• Podfigurna A, Meczekalski B. Functional hypothalamic amenorrhea: a stress-based disease. Endocrines. 2021 Sep;2(3):203–211. doi: 10.3390/endocrines2030020
   Google Scholar
• Boutari C, Pappas PD, Mintziori G, et al. The effect of underweight on female and male reproduction. Metabolism. 2020 Jun;107:154229.
   PubMed Web of Science ®Google Scholar
• Childs GV, Odle AK, MacNicol MC, et al. The importance of leptin to reproduction. Endocrinology. 2021 Feb 1;162(2):bqaa204.
   PubMed Web of Science ®Google Scholar
• Gierach M, Bruska-Sikorska M, Rojek M, et al. Hyperprolactinemia and insulin resistance. Endokrynol Pol. 2022;73(6):959–967. doi: 10.5603/EP.a2022.0075
   PubMed Web of Science ®Google Scholar
• Hoskova K, Kayton Bryant N, Chen ME, et al. Kisspeptin overcomes GnRH neuronal suppression secondary to hyperprolactinemia in humans. J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3515–25. doi: 10.1210/clinem/dgac166
   PubMed Web of Science ®Google Scholar
• Edinoff AN, Silverblatt NS, Vervaeke HE, et al. Hyperprolactinemia, clinical considerations, and infertility in women on antipsychotic medications. Psychopharmacol Bull. 2021 Mar 16;51(2):131–148.
   PubMedGoogle Scholar
• Fukuhara N, Nishiyama M, Iwasaki Y. Update in Pathogenesis, diagnosis, and therapy of prolactinoma. Cancers. 2022 Jul 24;14(15):3604.
   PubMed Web of Science ®Google Scholar
• Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013;6(3):168–175. doi: 10.4103/0974-1208.121400
   PubMedGoogle Scholar
• Mrowczynski OD, Langan ST, Rizk EB. Craniopharyngiomas: a systematic review and evaluation of the current intratumoral treatment landscape. Clin Neurol Neurosur. 2018 Mar 1;166:124–130. doi: 10.1016/j.clineuro.2018.01.039
   PubMed Web of Science ®Google Scholar
• Baines SJ. Chapter 51 - pharynx. In: Langley-Hobbs S, Demetriou J Ladlow J, editors. Feline soft tissue and general surgery [internet]. W.B. Saunders; 2014. p. 617–633. cited 2023 Aug 8 Available from:https://www.sciencedirect.com/science/article/pii/B9780702043369000512
   Google Scholar
• Sowithayasakul P, Boekhoff S, Bison B, et al. Pregnancies after Childhood Craniopharyngioma: results of kraniopharyngeom 2000/2007 and review of the literature. Neuroendocrinology. 2020 Dec 15;111(1–2):16–26.
   PubMed Web of Science ®Google Scholar
• Miljic D, Pekic S, Popovic V. Empty Sella. In: Feingold K, Anawalt B, Blackman M, Boyce A, Chrousos G Corpas E, eds et al. Endotext [internet]. South Dartmouth (MA): MDText.com, Inc; 2000 [cited 2023 Aug 9]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK532084/.
   Google Scholar
• Bendarska-Czerwińska A, Zmarzły N, Morawiec E, et al. Endocrine disorders and fertility and pregnancy: an update. Front Endocrinol. 2023[cited 2023 Aug 8]; 13: InternetAvailable from: doi: 10.3389/fendo.2022.970439
   PubMed Web of Science ®Google Scholar
• Jain D. A ray of hope for a woman with Sheehan’s syndrome. BMJ Case Rep. 2013 Feb 4;2013(feb04 1):bcr2012008445.
   PubMedGoogle Scholar
• Bathwal S, Sharma S, Agarwal N, et al. Fertility management in Kallmann syndrome: a step towards optimization. Int J Reprod Contracept Obstet Gynecol. 2017 May 25;6(6):2648–2650. doi: 10.18203/2320-1770.ijrcog20172373
   Google Scholar
• Melmed S. Fertility and fragrance: another cause of Kallmann syndrome. J Clin Invest. 2015 Jun 1;125(6):2275–2278.
   PubMed Web of Science ®Google Scholar
• Skałba P, Guz M. Hypogonadotropic hypogonadism in women. Endokrynol Pol. 2011;62(6):560–567.
   PubMed Web of Science ®Google Scholar
• Baird DT, Balen A, Escobar-Morreale HF, et al. Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update. 2012;18(5):586–599. doi: 10.1093/humupd/dms019
   PubMed Web of Science ®Google Scholar
• Collée J, Mawet M, Tebache L, et al. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2021 Oct;37(10):869–874. doi: 10.1080/09513590.2021.1958310
   PubMed Web of Science ®Google Scholar
• Sivanandy MS, Ha SK. The role of serum anti-mullerian hormone measurement in the diagnosis of polycystic ovary syndrome. Diagnostics. 2023 Jan;13(5):907. doi: 10.3390/diagnostics13050907
   Web of Science ®Google Scholar
• Sadeghi HM, Adeli I, Calina D, et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. 2022 Jan 6;23(2):583. doi: 10.3390/ijms23020583
   PubMed Web of Science ®Google Scholar
• Hubayter ZR, Popat V, Vanderhoof VH, et al. A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency. Fertil Steril. 2010 Oct;94(5):1769–1774. doi: 10.1016/j.fertnstert.2009.10.023
   PubMed Web of Science ®Google Scholar
• Piedade KC, Spencer H, Persani L, et al. Optimizing fertility in primary ovarian insufficiency: case report and literature review. Front Genet. 2021;12: [cited 2023 Aug 7]. InternetAvailable from: 10.3389/fgene.2021.676262
   PubMed Web of Science ®Google Scholar
• Chon SJ, Umair Z, Yoon MS. Premature ovarian insufficiency: past, present, and future. Front Cell Dev Biol. 2021;9:672890. doi: 10.3389/fcell.2021.672890
   PubMed Web of Science ®Google Scholar
• Sopiarz N, Sparzak PB Primary ovarian insufficiency.In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jun 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK589674/
   Google Scholar
• Nelson LM, Anasti JN, Kimzey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab. 1994 Nov;79(5):1470–1475. doi: 10.1210/jcem.79.5.7962345
   PubMed Web of Science ®Google Scholar
• Beau I, Touraine P, Meduri G, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest. 1998 Oct 1;102(7):1352–1359. doi: 10.1172/JCI3795
   PubMed Web of Science ®Google Scholar
• Desai SS, Achrekar SK, Sahasrabuddhe KA, et al. Functional characterization of two naturally occurring mutations (Val514Ala and Ala575Val) in follicle-stimulating hormone receptor. J Clin Endocrinol Metab. 2015 Apr;100(4):E638–645. doi: 10.1210/jc.2014-3662
   PubMed Web of Science ®Google Scholar
• Banerjee AA, Achrekar SK, Joseph S, et al. Functional characterization of two naturally occurring mutations V221G and T449N in the follicle stimulating hormone receptor. Mol Cell Endocrinol. 2017 Jan 15;440:69–79.
   PubMed Web of Science ®Google Scholar
• Lussiana C, Guani B, Mari C, et al. Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv. 2008 Dec;63(12):785–795. doi: 10.1097/OGX.0b013e31818957eb
   PubMed Web of Science ®Google Scholar
• Yang X, Yang L. Current understanding of the genomic abnormalities in premature ovarian failure: chance for early diagnosis and management. Front Med. 2023 Jun 2;10:1194865. doi: 10.3389/fmed.2023.1194865
   Web of Science ®Google Scholar
• Tsigkou A, Marzotti S, Borges L, et al. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J Clin Endocrinol Metab. 2008 Apr 1;93(4):1263–1269. doi: 10.1210/jc.2007-1675
   PubMed Web of Science ®Google Scholar
• Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al. Autoimmune diseases in patients with premature ovarian insufficiency-our Current state of knowledge. Int J Mol Sci. 2021 Mar 5;22(5):2594. doi: 10.3390/ijms22052594
   PubMed Web of Science ®Google Scholar
• Barros F, Carvalho F, Barros A, et al. Premature ovarian insufficiency: clinical orientations for genetic testing and genetic counseling. Porto Biomed J. 2020;5(3):e62. doi: 10.1097/j.pbj.0000000000000062
   PubMedGoogle Scholar
• Wang J, Sun X, Yang Z, et al. Epigenetic regulation in premature ovarian failure: a literature review. Front Physiol. 2022;13:998424. doi: 10.3389/fphys.2022.998424
   PubMed Web of Science ®Google Scholar
• Karavani G, Rottenstreich A, Schachter-Safrai N, et al. Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation. BMC Womens Health. 2021 May 13;21(1):201. doi: 10.1186/s12905-021-01343-z
   PubMed Web of Science ®Google Scholar
• Himpe J, Lammerant S, Van den Bergh L, et al. The impact of systemic oncological treatments on the fertility of adolescents and young adults—A systematic review. Life. 2023 May;13(5):1209. doi: 10.3390/life13051209
   PubMedGoogle Scholar
• Takae S, Kawamura K, Sato Y, et al. Analysis of late-onset ovarian insufficiency after ovarian surgery: retrospective study with 75 patients of post-surgical ovarian insufficiency. PLoS One. 2014 May 23;9(5):e98174. doi: 10.1371/journal.pone.0098174
   PubMed Web of Science ®Google Scholar
• Koyyada A, Orsu P. Role of hypothyroidism and associated pathways in pregnancy and infertility: clinical insights. Tzu-Chi Med J. 2020 Apr 10;32(4):312–317.
   PubMed Web of Science ®Google Scholar
• Jimenez-Ibañez LC, Conde-Gutierrez YDS, Torres-Trejo JA, et al. Hipotiroidismo asociado con infertilidad en mujeres en edad reproductiva. Ginecol Obstet México. 2020;88(5):321–329.
   Google Scholar
• Saran S, Gupta BS, Philip R, et al. Effect of hypothyroidism on female reproductive hormones. Indian J Endocrinol Metab. 2016;20(1):108–113. doi: 10.4103/2230-8210.172245
   PubMedGoogle Scholar
• Fröhlich E, Wahl R. The forgotten effects of thyrotropin-releasing hormone: metabolic functions and medical applications. Front Neuroendocrinol. 2019 Jan;52:29–43. doi: 10.1016/j.yfrne.2018.06.006
   PubMed Web of Science ®Google Scholar
• Vissenberg R, Manders VD, Mastenbroek S, et al. Pathophysiological aspects of thyroid hormone disorders/thyroid peroxidase autoantibodies and reproduction. Hum Reprod Update. 2015 May 1;21(3):378–387. doi: 10.1093/humupd/dmv004
   PubMed Web of Science ®Google Scholar
• Silva JF, Ocarino NM, Serakides R. Thyroid hormones and female reproduction†. Biol Reprod. 2018 Nov 1;99(5):907–921.
   PubMed Web of Science ®Google Scholar
• Joshi JV, Bhandarkar SD, Chadha M, et al. Menstrual irregularities and lactation failure may precede thyroid dysfunction or goitre. J Postgrad Med. 1993;39(3):137–141.
   PubMedGoogle Scholar
• Mazzilli R, Medenica S, Di Tommaso AM, et al. The role of thyroid function in female and male infertility: a narrative review. J Endocrinol Invest. 2023 Jan;46(1):15–26. doi: 10.1007/s40618-022-01883-7
   PubMed Web of Science ®Google Scholar
• Mintziori G, Kita M, Duntas L, et al. Consequences of hyperthyroidism in male and female fertility: pathophysiology and current management. J Endocrinol Invest. 2016 Aug;39(8):849–853. doi: 10.1007/s40618-016-0452-6
   PubMed Web of Science ®Google Scholar
• Maher JY, Gomez-Lobo V, Merke DP. The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum. Rev Endocr Metab Disord. 2023 Feb;24(1):71–83. doi: 10.1007/s11154-022-09770-5
   PubMed Web of Science ®Google Scholar
• Claahsen - Vander Grinten HL, Speiser PW, Ahmed SF, et al. Congenital adrenal hyperplasia—Current insights in pathophysiology, Diagnostics, and management. Endocr Rev. 2021 May 7;43(1):91–159. doi: 10.1210/endrev/bnab016
   Web of Science ®Google Scholar
• Gomes LG, Bachega TASS, Mendonca BB. Classic congenital adrenal hyperplasia and its impact on reproduction. Fertility And Sterility. 2019 Jan;111(1):7–12. doi: 10.1016/j.fertnstert.2018.11.037
   PubMed Web of Science ®Google Scholar
• Reichman DE, White PC, New MI, et al. Fertility in patients with congenital adrenal hyperplasia. Fertil Steril. 2014 Feb 1;101(2):301–309. doi: 10.1016/j.fertnstert.2013.11.002
   PubMed Web of Science ®Google Scholar
• Hagenfeldt K, Janson PO, Holmdahl G, et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Oxf Eng. 2008 Jul;23(7):1607–1613. doi: 10.1093/humrep/den118
   PubMed Web of Science ®Google Scholar
• Casteràs A, De Silva P, Rumsby G, et al. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf). 2009 Jun;70(6):833–837. doi: 10.1111/j.1365-2265.2009.03563.x
   PubMed Web of Science ®Google Scholar
• Lidaka L, Bekere L, Lazdane G, et al. Non-classical congenital adrenal hyperplasia-causing alleles in adolescent girls with PCOS and in risk group for PCOS development. Diagn Basel Switz. 2021 May 28;11(6):980.
   PubMedGoogle Scholar
• Erichsen MM, Husebye ES, Michelsen TM, et al. Sexuality and fertility in women with Addison’s disease. J Clin Endocrinol Metab. 2010 Sep 1;95(9):4354–4360.
   PubMed Web of Science ®Google Scholar
• Bensing S, Giordano R, Falorni A. Fertility and pregnancy in women with primary adrenal insufficiency. Endocrine. 2020 Nov;70(2):211–217. doi: 10.1007/s12020-020-02343-z
   PubMed Web of Science ®Google Scholar
• Betterle C, Greggio NA, Volpato M. Clinical review 93: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998 Apr;83(4):1049–1055. doi: 10.1210/jcem.83.4.4682
   PubMed Web of Science ®Google Scholar
• Falorni A, Laureti S, Candeloro P, et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril. 2002 Aug;78(2):270–279. doi: 10.1016/S0015-0282(02)03205-3
   PubMed Web of Science ®Google Scholar
• Vogt EC, Breivik L, Røyrvik EC, et al. Primary ovarian insufficiency in women with Addison’s disease. J Clin Endocrinol Metab. 2021 Mar 4;106(7):e2656–63. doi: 10.1210/clinem/dgab140
   PubMed Web of Science ®Google Scholar
• Castinetti F, Brue T. Impact of Cushing’s syndrome on fertility and pregnancy. Ann Endocrinol. 2022 Jun 1;83(3):188–190.
   PubMed Web of Science ®Google Scholar
• Ildefonso-Najarro SP, Plasencia-Dueñas EA, Benites-Moya CJ, et al. Pregnancy during the course of Cushing’s syndrome: a case report and literature review. Endocrinol Diabetes Metab Case Rep. InternetAvailable from. 2020 Apr 12;2020(1): [cited 2023 Jun 26]. doi: 10.1530/EDM-20-0022
   Google Scholar
• Ershadinia N, Tritos NA. Diagnosis and treatment of acromegaly: an Update. Mayo Clin Proc. 2022 Feb 1;97(2):333–346.
   PubMed Web of Science ®Google Scholar
• Pirchio R, Auriemma RS, Grasso LFS, et al. Fertility in acromegaly: a single-center experience of female patients during active disease and after disease remission. J Clin Endocrinol Metab. 2023 Feb 15;108(8):e583–e593. doi: 10.1210/clinem/dgad042
   PubMed Web of Science ®Google Scholar
• Cheng S, Grasso L, Martinez-Orozco JA, et al. Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol (Oxf). 2012 Feb;76(2):264–271. doi: 10.1111/j.1365-2265.2011.04180.x
   PubMed Web of Science ®Google Scholar
• Popescu AD, Carsote M, Valea A, et al. Approach of acromegaly during pregnancy. Diagnostics. 2022 Nov;12(11):2669. doi: 10.3390/diagnostics12112669
   Web of Science ®Google Scholar
• Assal A, Malcolm J, Lochnan H, et al. Preconception counselling for women with acromegaly: more questions than answers. Obstet Med. 2016 Mar;9(1):9–14. doi: 10.1177/1753495X15598699
   PubMed Web of Science ®Google Scholar
• Fichman V, da Costa Rde SS, Miglioli TC, et al. Association of obesity and anovulatory infertility. Einstein (São Paulo). 2020;18:eAO5150. doi: 10.31744/einstein_journal/2020AO5150
   PubMed Web of Science ®Google Scholar
• Belan M, Harnois-Leblanc S, Laferrère B, et al. Optimizing reproductive health in women with obesity and infertility. CMAJ Can Med Assoc J. 2018 Jun 18;190(24):E742–5. doi: 10.1503/cmaj.171233
   PubMed Web of Science ®Google Scholar
• Marinelli S, Napoletano G, Straccamore M, et al. Female obesity and infertility: outcomes and regulatory guidance. Acta Bio Medica Atenei Parm. 2022;93(4):e2022278.
   PubMedGoogle Scholar
• Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity’s impact. Fertil Steril. 2017 Apr;107(4):840–847. doi: 10.1016/j.fertnstert.2017.01.017
   PubMed Web of Science ®Google Scholar
• Chosich J, Bradford AP, Allshouse AA, et al. Acute recapitulation of the hyperinsulinemia and hyperlipidemia characteristic of metabolic syndrome suppresses gonadotropins. Obes Silver Spring Md. 2017 Mar;25(3):553–560. doi: 10.1002/oby.21754
   PubMed Web of Science ®Google Scholar
• Lainez NM, Coss D. Obesity, neuroinflammation, and reproductive function. Endocrinology. 2019 Nov 1;160(11):2719–2736.
   PubMed Web of Science ®Google Scholar
• Rachoń D, Teede H. Ovarian function and obesity–interrelationship, impact on women’s reproductive lifespan and treatment options. Mol Cell Endocrinol. 2010 Mar 25;316(2):172–179.
   PubMed Web of Science ®Google Scholar
• Szamatowicz M, Szamatowicz J. Proven and unproven methods for diagnosis and treatment of infertility. Adv Med Sci. 2020 Mar;65(1):93–96. doi: 10.1016/j.advms.2019.12.008
   PubMed Web of Science ®Google Scholar
• Infertility workup for the women’s Health Specialist: ACOG Committee opinion, number 781. Obstet Gynecol. 2019 Jun;133(6):e377–84. doi: 10.1097/AOG.0000000000003271
   PubMed Web of Science ®Google Scholar
• Islam H, Masud J, Islam YN, et al. An update on polycystic ovary syndrome: a review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Womens Health (Lond Engl). 2022 Aug 16;18:17455057221117966. doi: 10.1177/17455057221117966
   Google Scholar
• Hart RJ. Physiological aspects of female fertility: role of the environment, modern lifestyle, and genetics. Physiol Rev. 2016 Jul;96(3):873–909. doi: 10.1152/physrev.00023.2015
   PubMed Web of Science ®Google Scholar
• Bala R, Singh V, Rajender S, et al. Environment, lifestyle, and female infertility. Reprod Sci query. 2021 Mar;28(3):617–638. doi: 10.1007/s43032-020-00279-3
   PubMed Web of Science ®Google Scholar
• Prior JC, Naess M, Langhammer A, et al. Ovulation prevalence in women with spontaneous normal-length menstrual cycles – a population-based cohort from HUNT3, Norway. PLoS One. 2015 Aug 20;10(8):e0134473.
   PubMed Web of Science ®Google Scholar
• Raperport C, Chronopoulou E, Homburg R, et al. Endogenous progesterone in unexplained infertility: a systematic review and meta-analysis. J Assist Reprod Genet. 2023 Mar 1;40(3):509–524. doi: 10.1007/s10815-022-02689-5
   PubMedGoogle Scholar
• Sibal M. Ultrasound evaluation of adnexal pathology. In: Sibal M editor, Ultrasound in gynecology: an atlas and guide [internet]. Singapore:Springer Singapore. 2017; p. 319–361. [cited 2023 Aug 8]. Available from: doi: 10.1007/978-981-10-2714-7_9
   Google Scholar
• Serri O, Chik CL, Ur E, et al. Diagnosis and management of hyperprolactinemia. CMAJ Can Med Assoc J J Assoc Medicale Can. 2003 Sep 16;169(6):575–581.
   PubMed Web of Science ®Google Scholar
• Law BJ. Evaluation and management of hyperprolactinemia. Rev Endocrinol Nutr. 2005;13(s1):56–59.
   Google Scholar
• Patel SS, Bamigboye V. Hyperprolactinaemia. J Obstet Gynaecol. 2007 Jul;27(5):455–459. doi: 10.1080/01443610701406125
   PubMedGoogle Scholar
• Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018 Aug;110(3):364–379. doi: 10.1016/j.fertnstert.2018.05.004
   PubMed Web of Science ®Google Scholar
• Chang S, Dunaif A. Diagnosis of polycystic ovary syndrome: which criteria to use and when? Endocrinol Metab Clin North Am. 2021 Mar;50(1):11–23. doi: 10.1016/j.ecl.2020.10.002
   PubMed Web of Science ®Google Scholar
• Neven ACH, Laven J, Teede HJ, et al. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med. 2018 Jan;36(1):5–12. doi: 10.1055/s-0038-1668085
   PubMed Web of Science ®Google Scholar
• Wasilewski T, Łukaszewicz-Zając M, Wasilewska J, et al. Biochemistry of infertility. Clin Chim Acta Int J Clin Chem. 2020 Sep;508:185–190.
   PubMed Web of Science ®Google Scholar
• Gastaldelli A. Measuring and estimating insulin resistance in clinical and research settings. Obes Silver Spring Md. 2022 Aug;30(8):1549–1563. doi: 10.1002/oby.23503
   PubMed Web of Science ®Google Scholar
• Unuane D, Velkeniers B. Impact of thyroid disease on fertility and assisted conception. Best Pract Res Clin Endocrinol Metab. 2020 Jul;34(4):101378. doi: 10.1016/j.beem.2020.101378
   PubMed Web of Science ®Google Scholar
• Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid Off J Am Thyroid Assoc. 2017 Mar;27(3):315–389. doi: 10.1089/thy.2016.0457
   PubMed Web of Science ®Google Scholar
• Monteleone P, Parrini D, Faviana P, et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol. 2011;66(2):108–114. doi: 10.1111/j.1600-0897.2010.00961.x
   PubMed Web of Science ®Google Scholar
• Lancuba S, España De Marco MJ, Thomson MS, et al. Chapter 7 - endocrinological causes of female infertility. In: Laganà A Guglielmino A editors. Management of infertility [internet]. Academic Press; 2023. p. 65–70. [cited 2023 Aug 7]. Available from: https://www.sciencedirect.com/science/article/pii/B9780323899079000302.
   Google Scholar
• Fauser BCJM, Diedrich K, Devroey P, et al. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008 Jan 1;14(1):1–14. doi: 10.1093/humupd/dmm034
   PubMed Web of Science ®Google Scholar
• Coelho Neto MA, Ludwin A, Borrell A, et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol. 2018;51(1):10–20. doi: 10.1002/uog.18945
   PubMed Web of Science ®Google Scholar
• Capecce E, Pelanda M, Dicugno M, et al. La hormona antimülleriana como marcador de función ovárica. Rev Argent Endocrinol Metab. 2016 Sep;53(3):106–113. doi: 10.1016/j.raem.2016.06.003
   Google Scholar
• Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-mullerian hormone in women. Hum Reprod Update. 2014;20(3):370–385. doi: 10.1093/humupd/dmt062
   PubMed Web of Science ®Google Scholar
• Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020 Nov 1;105(11):3361–3373.
   PubMed Web of Science ®Google Scholar
• Cedars MI. Evaluation of female fertility-AMH and ovarian reserve testing. J Clin Endocrinol Metab. 2022 May 17;107(6):1510–1519.
   PubMed Web of Science ®Google Scholar
• Ulrich ND, Marsh EE. Ovarian reserve testing: a review of the options, their applications, and their limitations. Clin Obstet Gynecol. 2019 Jun;62(2):228–237. doi: 10.1097/GRF.0000000000000445
   PubMed Web of Science ®Google Scholar
• Rudnicka E, Kunicki M, Calik-Ksepka A, et al. Anti-Müllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int J Mol Sci. 2021 Nov 19;22(22):12507. doi: 10.3390/ijms222212507
   PubMed Web of Science ®Google Scholar
• Dewailly D, Robin G, Peigne M, et al. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 2016 Nov 20;22(6):709–724. doi: 10.1093/humupd/dmw027
   PubMed Web of Science ®Google Scholar
• Dumont A, Robin G, Dewailly D. Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome. Curr Opin Endocrinol Diabetes Obes. 2018 Dec;25(6):377–384. doi: 10.1097/MED.0000000000000445
   PubMedGoogle Scholar
• Kostrzewa M, Głowacka E, Stetkiewicz T, et al. Is serum anti-Müllerian hormone (AMH) assay a satisfactory measure for ovarian reserve estimation? A comparison of serum and peritoneal fluid AMH levels. Adv Clin Exp Med Off Organ Wroclaw Med Univ. 2020 Jul;29(7):853–856. doi: 10.17219/acem/121010
   PubMed Web of Science ®Google Scholar
• Broer SL, Broekmans FJM, Laven JSE, et al. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Human Reproduction Update. 2014 Sep 1;20(5):688–701.
   PubMed Web of Science ®Google Scholar
• di Clemente N, Racine C, Pierre A, et al. Anti-Müllerian hormone in female reproduction. Endocr Rev. 2021 Dec 1;42(6):753–782. doi: 10.1210/endrev/bnab012
   PubMed Web of Science ®Google Scholar
• Khan HL, Bhatti S, Suhail S, et al. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years. Reprod Biol Endocrinol RBE. 2019 Feb 11;17(1):20. doi: 10.1186/s12958-019-0464-0
   PubMedGoogle Scholar
• Bahgat NA, Denek Z. Relation between anti-mullerian hormone and blastocyst rate in patients less than 35 years old. Int J Reprod Contracept Obstet Gynecol. 2022 Apr 27;11(5):1351–1356.
   Google Scholar
• de Kat AC, Vander Schouw YT, Eijkemans MJC, et al. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. BMC Med. 2016 Oct 3;14(1):151. doi: 10.1186/s12916-016-0699-y
   PubMedGoogle Scholar
• Penzias A, Azziz R, Bendikson K, et al. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020 Dec 1;114(6):1151–1157. doi: 10.1016/j.fertnstert.2020.09.134
   PubMed Web of Science ®Google Scholar
• Steiner AZ, Herring AH, Kesner JS, et al. Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol. 2011 Apr;117(4):798–804. doi: 10.1097/AOG.0b013e3182116bc8
   PubMed Web of Science ®Google Scholar
• Tata B, El Houda Mimouni N, Barbotin AL, et al. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018 Jun;24(6):834–846. doi: 10.1038/s41591-018-0035-5
   PubMed Web of Science ®Google Scholar
• Butt MS, Saleem J, Aiman S, et al. Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age. BMC Womens Health. 2022 May 28;22(1):199. doi: 10.1186/s12905-022-01782-2
   PubMed Web of Science ®Google Scholar
• Piltonen TT, Komsi E, Morin-Papunen LC, et al. AMH as part of the diagnostic PCOS workup in large epidemiological studies. Eur J Endocrinol. 2023 Jun 1;188(6):547–554. doi: 10.1093/ejendo/lvad065
   PubMed Web of Science ®Google Scholar
• Hagen CP, Vestergaard S, Juul A, et al. Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study. Fertil Steril. 2012 Dec;98(6):1602–1608.e2. doi: 10.1016/j.fertnstert.2012.08.008
   PubMed Web of Science ®Google Scholar
• Tal R, Seifer DB, Wantman E, et al. Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for assisted reproductive technology clinic outcome reporting system database for 2012–2013. Fertil Steril. 2018 Feb 1;109(2):258–265. doi: 10.1016/j.fertnstert.2017.10.021
   PubMed Web of Science ®Google Scholar
• Yin J, Chang HM, Li R, et al. Recent progress in the treatment of women with diminished ovarian reserve. Gynecol Obstet Clin Med. 2021 Dec 1;1(4):186–189.
   Google Scholar
• Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol. 2017 Aug;217(2):129–140. doi: 10.1016/j.ajog.2017.02.027
   PubMed Web of Science ®Google Scholar
• Sabek EAS, Saleh OI, Ahmed HA. Ultrasound in evaluating ovarian reserve, is it reliable? Egypt J Radiol Nucl Med. 2015 Dec 1;46(4):1343–1348.
   Google Scholar
• Maseelall PB, Hernandez-Rey AE, Oh C, et al. Antral follicle count is a significant predictor of livebirth in in vitro fertilization cycles. Fertil Steril. 2009 Apr 1;91(4):1595–1597.
   PubMed Web of Science ®Google Scholar
• Scheffer GJ, Broekmans FJM, Dorland M, et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril. 1999 Nov 1;72(5):845–851. doi: 10.1016/S0015-0282(99)00396-9
   PubMed Web of Science ®Google Scholar
• Broer SL, Dólleman M, Opmeer BC, et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46–54. doi: 10.1093/humupd/dmq034
   PubMed Web of Science ®Google Scholar
• Gaskins AJ, Nassan FL, Chiu YH, et al. Dietary patterns and outcomes of assisted reproduction. Am J Obstet Gynecol. 2019 Jun;220(6):.e567.1–.e567.18. doi: 10.1016/j.ajog.2019.02.004
   Web of Science ®Google Scholar
• Salas-Huetos A, Babio N, Carrell DT, et al. Adherence to the Mediterranean diet is positively associated with sperm motility: a cross-sectional analysis. Sci Rep. 2019 Mar 4;9(1):3389. doi: 10.1038/s41598-019-39826-7
   PubMedGoogle Scholar
• Barrea L, Arnone A, Annunziata G, et al. Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients. 2019 Sep 23;11(10):2278. doi: 10.3390/nu11102278
   PubMed Web of Science ®Google Scholar
• Grammatikopoulou MG, Lampropoulou M, Goulis DG. Chapter 41 - Mediterranean diet and female fertility: cross-talk of an evidence-based approach. In: Preedy V Watson R editors, The Mediterranean diet. Second Academic Press; 2020p. 473–482[cited 2023 Jun 27]. InternetAvailable from: https://www.sciencedirect.com/science/article/pii/B9780128186497000412
   Google Scholar
• Silvestris E, Lovero D, Palmirotta R. Nutrition and female fertility: an interdependent correlation. Front Endocrinol. 2019;10:346. doi: 10.3389/fendo.2019.00346
   PubMed Web of Science ®Google Scholar
• Garruti G, Depalo R, De Angelis M. Weighing the impact of diet and lifestyle on female reproductive function. Curr Med Chem. 2019;26(19):3584–3592. doi: 10.2174/0929867324666170518101008
   PubMed Web of Science ®Google Scholar
• Jurczewska J, Szostak-Węgierek D. The influence of diet on ovulation disorders in women-A narrative review. Nutrients. 2022 Apr 8;14(8):1556.
   PubMed Web of Science ®Google Scholar
• Kohil A, Chouliaras S, Alabduljabbar S, et al. Female infertility and diet, is there a role for a personalized nutritional approach in assisted reproductive technologies? A Narrative Rev Front Nutr. 2022;9:927972. doi: 10.3389/fnut.2022.927972
   PubMed Web of Science ®Google Scholar
• Skoracka K, Ratajczak AE, Rychter AM, et al. Female fertility and the nutritional approach: the most essential aspects. Adv Nutr. 2021 Jun 17;12(6):2372–2386. doi: 10.1093/advances/nmab068
   PubMed Web of Science ®Google Scholar
• Karayiannis D, Kontogianni MD, Mendorou C, et al. Adherence to the Mediterranean diet and IVF success rate among non-obese women attempting fertility. Hum Reprod Oxf Eng. 2018 Mar 1;33(3):494–502. doi: 10.1093/humrep/dey003
   PubMed Web of Science ®Google Scholar
• Budani MC, Tiboni GM. Nutrition, female fertility and in vitro fertilization outcomes. Reprod Toxicol. 2023 Jun 1;118:108370. doi: 10.1016/j.reprotox.2023.108370
   PubMed Web of Science ®Google Scholar
• Gaskins AJ, Chiu YH, Williams PL, et al. Maternal whole grain intake and outcomes of in vitro fertilization. Fertil Steril. 2016 Jun;105(6):1503–1510.e4. doi: 10.1016/j.fertnstert.2016.02.015
   PubMed Web of Science ®Google Scholar
• Chen MS, Wang DY, Gong HY, et al. La relación entre la fibra dietética y la infertilidad femenina en los Estados Unidos: encuesta nacional de salud y nutrición, 2013-2018. Nutrición Hospitalaria. 2022 Dec;39(6):1333–1340. doi: 10.20960/nh.04056
   PubMedGoogle Scholar
• Zarezadeh R, Mehdizadeh A, Leroy JLMR, et al. Action mechanisms of n-3 polyunsaturated fatty acids on the oocyte maturation and developmental competence: potential advantages and disadvantages. Journal Cellular Physiology. 2019 Feb;234(2):1016–1029. doi: 10.1002/jcp.27101
   PubMed Web of Science ®Google Scholar
• Stanhiser J, Jukic AMZ, Steiner AZ. Serum omega-3 and omega-6 fatty acid concentrations and natural fertility. Hum Reprod Oxf Eng. 2020 Apr 28;35(4):950–957.
   PubMed Web of Science ®Google Scholar
• Abodi M, De Cosmi V, Parazzini F, et al. Omega-3 fatty acids dietary intake for oocyte quality in women undergoing assisted reproductive techniques: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2022 Aug;275:97–105.
   PubMed Web of Science ®Google Scholar
• Lass A, Belluzzi A. Omega-3 polyunsaturated fatty acids and IVF treatment. Reprod Biomed Online. 2019 Jan;38(1):95–99. doi: 10.1016/j.rbmo.2018.10.008
   PubMed Web of Science ®Google Scholar
• Chiu YH, Karmon AE, Gaskins AJ, et al. Serum omega-3 fatty acids and treatment outcomes among women undergoing assisted reproduction. Hum Reprod Oxf Eng. 2018 Jan 1;33(1):156–165. doi: 10.1093/humrep/dex335
   PubMed Web of Science ®Google Scholar
• Skoracka K, Ratajczak AE, Rychter AM, et al. Female fertility and the nutritional approach: the most essential aspects. Adv Nutr Bethesda Md. 2021 Dec 1;12(6):2372–2386. doi: 10.1093/advances/nmab068
   PubMed Web of Science ®Google Scholar
• Lyngsø J, Ramlau-Hansen CH, Bay B, et al. Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose–response meta-analysis. Clin Epidemiol. 2017 Dec 15;9:699–719. doi: 10.2147/CLEP.S146496
   PubMed Web of Science ®Google Scholar
• de Angelis C, Nardone A, Garifalos F, et al. Smoke, alcohol and drug addiction and female fertility. Reprod Biol Endocrinol. 2020 Mar 12;18(1):21. doi: 10.1186/s12958-020-0567-7
   PubMed Web of Science ®Google Scholar
• Emokpae MA, Brown SI. Effects of lifestyle factors on fertility: practical recommendations for modification. Reprod Fertil. 2021 Jan 8;2(1):R13–26.
   PubMedGoogle Scholar
• Corsi DJ, Murphy MSQ. The effects of opioids on female fertility, pregnancy and the breastfeeding mother-infant dyad: a review. Basic Clin Pharmacol Toxicol. 2021;128(5):635–641. doi: 10.1111/bcpt.13577
   PubMed Web of Science ®Google Scholar
• Alvarez S. Do some addictions interfere with fertility? Fertil Steril. 2015 Jan 1;103(1):22–26.
   PubMed Web of Science ®Google Scholar
• Wang H, Dey SK, Maccarrone M. Jekyll and Hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev. 2006 Aug 1;27(5):427–448.
   PubMed Web of Science ®Google Scholar
• Hakimi O, Cameron LC. Effect of exercise on ovulation: a systematic review. Sports Med. 2017 Aug 1;47(8):1555–1567.
   PubMed Web of Science ®Google Scholar
• Mallinson RJ, Gibbs JC, De Souza MJ. Impact of physical activity and exercise on female reproductive potential. In: Vaamonde D, du Plessis S, and Agarwal A editors. Exercise and human reproduction: induced fertility disorders and possible therapies [internet]. NY: Springer; 2016; p. 167–185. [cited 2023 Jun 6]. Available from. doi: 10.1007/978-1-4939-3402-7_11
   Google Scholar
• Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021 Jul 6;326(1):65–76.
   PubMed Web of Science ®Google Scholar
• Adashi EY, Adashi EY. Clomiphene citrate: mechanism(s) and site(s) of action—a hypothesis revisited. Fertil Steril. 1984 Sep;42(3):331–344. doi: 10.1016/S0015-0282(16)48069-6
   PubMed Web of Science ®Google Scholar
• Palomba S. Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2015 May 1;100(5):1742–1747.
   PubMed Web of Science ®Google Scholar
• Cohlen BJ. Ovulation induction versus controlled ovarian hyperstimulation. In: Ovulation induction. CRC Press; 2016.
   Google Scholar
• Christou F, Pitteloud N, Gomez F. The induction of ovulation by pulsatile administration of GnRH: an appropriate method in hypothalamic amenorrhea. Gynecol Endocrinol. 2017 Aug 3;33(8):598–601.
   PubMed Web of Science ®Google Scholar
• Scheiber MD, Liu JH The use of gonadotropin-releasing hormone to induce ovulation. Glob Libr Womens Med [Internet]. 2011 [cited 2023 Jul 1]; Available from: https://www.glowm.com/section-view/item/339
   Google Scholar
• Martin KA, Hall JE, Adams JM, et al. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 1993 Jul;77(1):125–129. doi: 10.1210/jcem.77.1.8325934
   PubMed Web of Science ®Google Scholar
• Pfeifer S, Butts S, Dumesic D, et al. Electronic address: [email protected], practice Committee of the American Society for reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016 Dec;106(7):1634–1647. doi: 10.1016/j.fertnstert.2016.08.048
   PubMed Web of Science ®Google Scholar
• Penzias A, Bendikson K, Falcone T, et al. Electronic address: [email protected], practice Committee of the American Society for reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020 Feb;113(2):305–322. doi: 10.1016/j.fertnstert.2019.10.014
   PubMed Web of Science ®Google Scholar
• O’Leary K. Hyperprolactinemia: effect on reproduction, diagnosis, and management. In: Allahbadia G, Ata B, Lindheim S, Woodward B, and Bhagavath B editors. Textbook of assisted reproduction [internet]. Singapore: Springer; 2020; p. 141–148. [cited 2023 Jun 6]. Available from. doi: 10.1007/978-981-15-2377-9_16
   Google Scholar
• Halperin Rabinovich I, Cámara Gómez R, García Mouriz M, et al. Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia. Endocrinol Nutr Engl Ed. 2013 Jun 1;60(6):308–319.
   Google Scholar
• Overview | Fertility problems: assessment and treatment | Guidance | NICE [Internet]. NICE; 2013 [cited 2023 Jun 8]. Available from: https://www.nice.org.uk/guidance/cg156/
   Google Scholar
• Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Feb;96(2):273–288. doi: 10.1210/jc.2010-1692
   PubMed Web of Science ®Google Scholar
• Dogansen SC, Cikrikcili U, Oruk G, et al. Dopamine agonist-induced impulse control disorders in patients with prolactinoma: a cross-sectional multicenter study. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2527–2534. doi: 10.1210/jc.2018-02202
   PubMed Web of Science ®Google Scholar
• Webster J, Piscitelli G, Polli A, et al. A Comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med. 1994 Oct 6;331(14):904–909. doi: 10.1056/NEJM199410063311403
   PubMed Web of Science ®Google Scholar
• Maiter D. Prolactinoma and pregnancy: from the wish of conception to lactation. Ann Endocrinol. 2016 Jun 1;77(2):128–134.
   PubMed Web of Science ®Google Scholar
• Edinoff AN, Sathivadivel N, McNeil SE, et al. Antipsychotic use in pregnancy: patient mental health challenges, teratogenicity, pregnancy complications, and postnatal risks. Neurol Int. 2022 Mar;14(1):62–74. doi: 10.3390/neurolint14010005
   PubMed Web of Science ®Google Scholar
• Lim SS, Hutchison SK, Van Ryswyk E, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019 Mar 28;3(3): CD007506. doi: 10.1002/14651858.CD007506.pub4
   PubMedGoogle Scholar
• Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014 Jul 10;371(2):119–129. doi: 10.1056/NEJMoa1313517
   PubMed Web of Science ®Google Scholar
• Liu Z, Geng Y, Huang Y, et al. Letrozole compared with clomiphene citrate for polycystic ovarian syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2023 Mar 1;141(3):523–534. doi: 10.1097/AOG.0000000000005070
   PubMed Web of Science ®Google Scholar
• Franik S, Eltrop SM, Kremer JA, et al. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;2018(5): [[cited 2023 Jun 8].]. Internet Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub3/full
   Google Scholar
• Tsiami AP, Goulis DG, Sotiriadis AI, et al. Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Horm Athens Greece. 2021 Sep;20(3):449–461. doi: 10.1007/s42000-021-00289-z
   PubMedGoogle Scholar
• Homburg R. Clomiphene citrate–end of an era? A mini-review. Hum Reprod Oxf Eng. 2005 Aug;20(8):2043–2051. doi: 10.1093/humrep/dei042
   PubMed Web of Science ®Google Scholar
• Brown J, Farquhar C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD002249.
   PubMedGoogle Scholar
• Heard MJ, Pierce A, Carson SA, et al. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril. 2002 Apr 1;77(4):669–673. doi: 10.1016/S0015-0282(01)03266-6
   PubMed Web of Science ®Google Scholar
• Sharpe A, Morley LC, Tang T, et al. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst Rev [Internet]. 2019; (12): [[cited 2023 Jun 8].]. Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013505/information
   Web of Science ®Google Scholar
• Webber L, Davies M, Anderson R, et al.; European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod Oxf Eng. 2016 May;31(5):926–937.
   PubMed Web of Science ®Google Scholar
• Fraison E, Crawford G, Casper G, et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod Biomed Online. 2019 Sep;39(3):467–476. doi: 10.1016/j.rbmo.2019.04.019
   PubMed Web of Science ®Google Scholar
• Popat VB, Vanderhoof VH, Calis KA, et al. Normalization of serum LH levels in women with 46,XX spontaneous primary ovarian insufficiency. Fertil Steril. 2008 Feb;89(2):429–433. doi: 10.1016/j.fertnstert.2007.02.032
   PubMed Web of Science ®Google Scholar
• Popat VB, Calis KA, Kalantaridou SN, et al. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab. 2014 Sep;99(9):3418–3426. doi: 10.1210/jc.2013-4145
   PubMed Web of Science ®Google Scholar
• Committee Opinion No. 698: hormone therapy in primary ovarian insufficiency. Obstet Gynecol. 2017 May;129(5):e134. doi: 10.1097/AOG.0000000000002044
   PubMed Web of Science ®Google Scholar
• Alzubaidi NH, Chapin HL, Vanderhoof VH, et al. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol. 2002 May;99(5 Pt 1):720–725. doi: 10.1097/00006250-200205000-00009
   PubMed Web of Science ®Google Scholar
• Orshan SA, Ventura JL, Covington SN, et al. Women with spontaneous 46,XX primary ovarian insufficiency (hypergonadotropic hypogonadism) have lower perceived social support than control women. Fertil Steril. 2009 Aug;92(2):688–693. doi: 10.1016/j.fertnstert.2008.07.1718
   PubMed Web of Science ®Google Scholar
• Davis M, Ventura JL, Wieners M, et al. The psychosocial transition associated with spontaneous 46,XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health. Fertil Steril. 2010 May 1;93(7):2321–2329. doi: 10.1016/j.fertnstert.2008.12.122
   PubMed Web of Science ®Google Scholar
• Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril. 2015 Sep 1;104(3):545–553. doi: 10.1016/j.fertnstert.2015.05.028
   PubMed Web of Science ®Google Scholar
• Poppe K. Management of endocrine disease: thyroid and female infertility: more questions than answers?! Eur J Endocrinol. 2021 Apr 1;184(4):R123–35.
   PubMedGoogle Scholar
• Weghofer A, Barad DH, Darmon S, et al. What affects functional ovarian reserve, thyroid function or thyroid autoimmunity? Reprod Biol Endocrinol. 2016 May 10;14(1):26. doi: 10.1186/s12958-016-0162-0
   PubMedGoogle Scholar
• Tańska K, Gietka-Czernel M, Glinicki P, et al. Thyroid autoimmunity and its negative impact on female fertility and maternal pregnancy outcomes. Front Endocrinol. 2023;13: [cited 2023 Jun 6]. InternetAvailable from: 10.3389/fendo.2022.1049665
   PubMed Web of Science ®Google Scholar
• Poppe K, Bisschop P, Fugazzola L, et al. 2021 European thyroid association guideline on thyroid disorders prior to and during assisted reproduction. Eur Thyroid J. 2021 Feb;9(6):281–295. doi: 10.1159/000512790
   PubMed Web of Science ®Google Scholar
• Anand G, Beuschlein F. Management of endocrine disease: fertility, pregnancy and lactation in women with adrenal insufficiency. Eur J Endocrinol. 2018 Feb;178(2):R45–53. doi: 10.1530/EJE-17-0975
   PubMed Web of Science ®Google Scholar
• Stikkelbroeck N, Falhammar H, Reisch N, et al. Management of endocrine disease: gonadal dysfunction in congenital adrenal hyperplasia. Eur J Endocrinol. 2021 Mar 1;184(3):R85–97. doi: 10.1530/EJE-20-1093.
   PubMedGoogle Scholar
• Carrière C, Nguyen LS, Courtillot C, et al. Fertility and pregnancy outcomes in women with nonclassic 21-hydroxylase deficiency. Clin Endocrinol (Oxf). 2023;98(3):315–322. doi: 10.1111/cen.14842
   PubMed Web of Science ®Google Scholar
• Zhu L, Zhou B, Zhu X, et al. Association between body mass index and female infertility in the United States: data from National Health and Nutrition examination survey 2013–2018. Int J Gen Med. 2022 Feb 19;15:1821–1831.
   PubMed Web of Science ®Google Scholar
• Yumuk V, Tsigos C, Fried M, et al. European guidelines for obesity management in adults. Obes Facts. 2015 Dec;8(6):402–424. doi: 10.1159/000442721
   PubMed Web of Science ®Google Scholar
• Taghavi SA, Wely M, Jahanfar S, et al. Pharmacological and non‐pharmacological strategies for obese women with subfertility. Cochrane Database Syst Rev. 2021 Mar 25;2021(3): CD012650. doi:10.1002/14651858.CD012650.pub2
   Google Scholar
• Hazlehurst JM, Singh P, Bhogal G, et al. How to manage weight loss in women with obesity and PCOS seeking fertility? Clin Endocrinol (Oxf). 2022;97(2):208–216. doi: 10.1111/cen.14726
   PubMed Web of Science ®Google Scholar
• Jäger P, Wolicki A, Spohnholz J, et al. Review: sex-specific aspects in the bariatric treatment of severely obese women. Int J Environ Res Public Health. 2020 Jan;17(8):2734. doi: 10.3390/ijerph17082734
   PubMed Web of Science ®Google Scholar
• Güven B, Ibrahimoğlu Ö, Seyit H. Preoperative weight loss as a predictor of short and midterm postoperative weight loss in patients undergoing bariatric surgery. Bariatr Surg Pract Patient Care. 2023 Feb 13;18(1):8–12.[[cited 2023 Jun 6]; Available from]. Internet: https://www.liebertpub.com/doi/abs/10.1089/bari.2022.0060
   PubMed Web of Science ®Google Scholar
• Gaskins AJ, Chavarro JE. Diet and fertility: a review. Am J Obstet Gynecol. 2018 Apr;218(4):379–389. doi: 10.1016/j.ajog.2017.08.010
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Métneki J, Dudás I. The effect of preconceptional multivitamin supplementation on fertility. Int J Vitam Nutr Res Int Z Vitam- Ernahrungsforschung J Int Vitaminol Nutr. 1996;66(1):55–58.
   PubMed Web of Science ®Google Scholar
• Gaskins AJ, Afeiche M, Wright DL, et al. Dietary folate and reproductive success among women undergoing assisted reproduction. Obstet Gynecol. 2014 Oct;124(4):801–809. doi: 10.1097/AOG.0000000000000477
   PubMed Web of Science ®Google Scholar
• Kadir M, Hood RB, Mínguez-Alarcón L, et al. Folate intake and ovarian reserve among women attending a fertility center. Fertil Steril. 2022 Jan;117(1):171–180. doi: 10.1016/j.fertnstert.2021.09.037
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhi X. Roles of vitamin D in reproductive systems and assisted reproductive technology. Endocrinology. 2020 Apr 1;161(4):bqaa023.
   PubMed Web of Science ®Google Scholar
• Chiu YH, Chavarro JE, Souter I. Diet and female fertility: doctor, what should I eat? Fertil Steril. 2018 Sep;110(4):560–569. doi: 10.1016/j.fertnstert.2018.05.027
   PubMed Web of Science ®Google Scholar
• He C, Lin Z, Robb SW, et al. Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients. 2015 Jun 8;7(6):4555–4577. doi: 10.3390/nu7064555
   PubMed Web of Science ®Google Scholar
• Chu J, Gallos I, Tobias A, et al. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Hum Reprod Oxf Eng. 2018 Jan 1;33(1):65–80. doi: 10.1093/humrep/dex326
   PubMed Web of Science ®Google Scholar
• Abadia L, Gaskins AJ, Chiu YH, et al. Serum 25-hydroxyvitamin D concentrations and treatment outcomes of women undergoing assisted reproduction. Am J Clin Nutr. 2016 Sep;104(3):729–735. doi: 10.3945/ajcn.115.126359
   PubMed Web of Science ®Google Scholar
• Naderi Z, Kashanian M, Chenari L, et al. Evaluating the effects of administration of 25-hydroxyvitamin D supplement on serum anti-mullerian hormone (AMH) levels in infertile women. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2018 May;34(5):409–412. doi: 10.1080/09513590.2017.1410785
   PubMed Web of Science ®Google Scholar
• Arslan S, Akdevelioğlu Y. The relationship between female reproductive functions and Vitamin D. J Am Coll Nutr. 2018 Aug;37(6):546–551. doi: 10.1080/07315724.2018.1431160
   PubMed Web of Science ®Google Scholar
• Smits RM, Mackenzie-Proctor R, Fleischer K, et al. Antioxidants in fertility: impact on male and female reproductive outcomes. Fertil Steril. 2018 Sep;110(4):578–580. doi: 10.1016/j.fertnstert.2018.05.028
   PubMed Web of Science ®Google Scholar
• Showell MG, Mackenzie-Proctor R, Jordan V, et al. Antioxidants for female subfertility. Cochrane Database Syst Rev. 2020 Aug 27;8(8): CD007807. doi:10.1002/14651858.CD007807.pub4
   PubMedGoogle Scholar
• Younis N, Mahasneh A. Probiotics and the envisaged role in treating human infertility. Middle East Fertil Soc J. 2020 Oct 21;25(1):33.
   Web of Science ®Google Scholar
• Cissen M, Bensdorp A, Cohlen BJ, et al. Assisted reproductive technologies for male subfertility. Cochrane Database Syst Rev. 2016;2016(2): [cited 2023 Jun 8]. Internet Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000360.pub5/full
   Google Scholar
• Bhattacharya S, Harrild K, Mollison J, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ. 2008 Aug 7;337(aug07 2):a716. doi: 10.1136/bmj.a716
   PubMedGoogle Scholar
• Goldman MB, Thornton KL, Ryley D, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the forty and over treatment trial (FORT-T). Fertil Steril. 2014 Jun;101(6):1574-1581.e1–2. doi: 10.1016/j.fertnstert.2014.03.012
   Web of Science ®Google Scholar
• Abbara A, Clarke SA, Dhillo WS. Novel concepts for inducing final oocyte maturation in in vitro fertilization treatment. Endocr Rev. 2018 Oct 1;39(5):593–628.
   PubMed Web of Science ®Google Scholar
• Herman T, Csehely S, Orosz M, et al. Impact of endocrine disorders on IVF outcomes: results from a large, single-centre, prospective study. Reprod Sci Thousand Oaks Calif. 2023 Jun;30(6):1878–1890. doi: 10.1007/s43032-022-01137-0
   PubMed Web of Science ®Google Scholar
• Tobler KJ, Zhao Y, Weissman A, et al. Worldwide survey of IVF practices: trigger, retrieval and embryo transfer techniques. Arch Gynecol Obstet. 2014 Sep;290(3):561–568. doi: 10.1007/s00404-014-3232-6
   PubMed Web of Science ®Google Scholar
• Nastri CO, Ferriani RA, Rocha IA, et al. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010 Feb;27(2–3):121–128. doi: 10.1007/s10815-010-9387-6
   PubMed Web of Science ®Google Scholar